Doctor Ho Sik Shin

Kosin University School of Medicine, Busan (Korea (Republic of))

Membership: ESC Professional Member

Follow

Contributor content

Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease

Presentation

Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease

ESC 365 is supported by

novartis

Explore sponsored resources